As the understanding of obesity science evolves, focus is shifting from simply reducing body weight to treating obesity as a complex, chronic disease affecting almost every system of the body. Along with new therapies, a growing understanding of obesity’s biological underpinnings is changing how healthcare professionals think about treatment, long-term health, and the future of personalized care.

While traditionally viewed as a matter of personal responsibility, scientists now believe obesity is a complex, multifactorial disease shaped by biological, genetic, environmental, behavioral, and social factors. That shift in thinking is helping to transform both patient care and scientific research. Ultimately, treating obesity may also improve a wide range of related chronic conditions.

“I would love to celebrate the fact that obesity is seen as a disease, but I don’t know that we're there yet,” says Lisa Tarasenko, Global Medical Senior Director, Obesity, at Pfizer. “There's still a lot of misunderstanding about obesity, and many people living with it continue to face stigma and judgment.”

Obesity isn’t just about weight

We know obesity affects much more than the number on a scale. It’s linked to changes throughout the body, including inflammation, insulin resistance, altered lipid metabolism, and dysfunction across multiple organ systems.1 These biological changes help explain why obesity is connected to numerous other chronic diseases.

Obesity has been associated with more than 200 health conditions and complications, including:2,3

  • Type 2 diabetes

  • Cardiovascular disease

  • Obstructive sleep apnea

  • Osteoarthritis

  • Liver disease

  • Some forms of cancer

“What we’ve seen is that when obesity is treated effectively, many people also see improvements in other health conditions linked to obesity,” Tarasenko says. “There is a growing recognition that obesity isn’t just a risk factor for other diseases. It can play an important role in the development and progression of many serious health conditions.”

A chronic disease requiring long-term care

Scientists are also recognizing that obesity often requires ongoing treatment. With the rise of new therapies like GLP-1s, many people assume obesity medications are only temporary tools to help lose weight. But researchers now understand that obesity is much like other chronic diseases requiring long-term management.

“People often think, ‘I'm going to take this medicine, lose the weight, and then be done,’” Tarasenko says. “But for many people, the challenge isn’t just losing weight, it’s maintaining it. Obesity is a chronic disease, and the right approach to treatment often needs to be tailored to the individual and adjusted over time.”

Studies have shown that many patients regain weight after discontinuing treatment, highlighting the importance of long-term disease management.4 But not everyone’s experience is the same. For some people living with chronic obesity, biological changes in appetite and energy balance can make weight regain more likely after weight loss.5 As a result, long-term management strategies should be individualized rather than based on the assumption that treatment can routinely be stopped once weight is lost.

New therapies are changing what’s possible

Obesity research has taken off over the past several years. Previously, a person taking obesity medications often experienced relatively minor weight loss. In some cases, therapies were limited by safety concerns or poor tolerability. Now, newer treatments are changing expectations.

“Ten percent weight loss used to be considered a major achievement,” Tarasenko says. “Today, some of the newer obesity medicines are delivering levels of weight loss that would have seemed almost unimaginable a decade ago. In clinical trials, some therapies have approached 30% average weight loss, although results vary depending on the treatment and the patient.”

Today's treatments build on decades of research into GLP-1 biology. GLP-1 receptor agonists were first introduced clinically for type 2 diabetes, and then studies demonstrated important effects on appetite regulation, energy intake, body weight, and obesity-related outcomes.6

The next frontier: personalized obesity medicine

While today’s treatments represent a major step forward, many researchers believe we’re still in the early days of obesity medicine. Instead of searching for one treatment that works for everyone, the focus is increasingly shifting toward understanding which approaches work best for different people.

“I think the future is going to be much more personalized,” says Tarasenko. “Obesity doesn't look the same in every person, and not everyone responds to treatment the same way. The more we learn, the better we'll be at finding the right approach for the individual in front of us.”

Researchers are currently studying different obesity phenotypes, or the biological and behavioral characteristics that may impact how someone responds to treatment. Some patients could benefit from lower doses of obesity medications taken over longer periods of time. Others might respond better to combination therapies or medicines targeting different biological pathways.7

“A lot is going to change over the next five to ten years,” Tarasenko says.

Scientists are also exploring entirely new mechanisms beyond GLP-1s, with hundreds of investigational therapies currently in development. Future research aims not only to improve weight loss but also to reduce side effects, preserve muscle mass, and potentially develop therapies that offer lasting benefits after treatment ends.8

Looking beyond the scale

What does successful obesity treatment look like? Researchers are increasingly looking beyond the number on the scale and asking broader questions about health, function, and quality of life. One area of active study is body composition, including how to maximize fat loss while supporting muscle health and physical function during weight loss.9

At the same time, researchers continue to measure how patients themselves define success. For some patients, Tarasenko says, success looks like having more energy, being able to work out more easily, and having less barriers to “doing what they want.”

Ultimately, the future of obesity care may be measured not simply by pounds lost but by healthier lives lived. As scientific understanding grows, obesity research continues moving beyond weight loss alone and toward reducing the burden of chronic disease. That means personalizing treatment, improving quality of life, and helping people who live with obesity receive the same understanding and medical care afforded to other chronic diseases.